Next, check with your insurance company to understand their specific requirements for coverage
Promising drug categories include: cholesterol-lowering drugs (e.g., aramchol), 104 FXR agonists (e.g., obeticholic acid, 105 tropifexor), 106 PPAR agonists [e.g., elafibranor (PPAR /), 107 saroglitazar (PPAR /), 108 pemafibrate (PPAR) 109 ], Thyroid hormone receptor agonists (e.g., resmetirom), 110 and FGF21 analog (e.g., pegbelfermin)
They also show if you have other health issues that need attention
32,52 As described in Table 3, the overall results from these RCTs have identified a general greater efficacy on HbA1c reduction and on weight reduction of injectable long-acting GLP-1RAs
Following a year of treatment, the average weight reduction was 3.6 percent among participants who discontinued their treatment early, compared to 6.8 percent for those who discontinued their treatment late
What can you afford